Novaferon (recombinant anti-tumor and anti-virus protein) / Genova  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Novaferon (recombinant anti-tumor and anti-virus protein) / Genova
ChiCTR-TRC-10001000: A pahse II trial of Novafenon for Locally Advanced Pancreatic Adenocarcinoma

Suspended
2
40
 
Novaferon, intramuscular injection, 10ug, thrice weekly for week 1-13 ;Novaferon, intramuscular injection, 10μg, thrice weekly for week 1; followed by 20μg, thrice weekly for week 2-13 ;Scheme A or Scheme B according to the first stage result
Shanghai Changhai Hospital; Genova Biotech Company, Ltd, Genova Biotech Company, Ltd. , National Novel Drug Development plan
Locally Advanced Pancreatic Adenocarcinoma.
 
 
NCT01386242: Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Completed
2
108
RoW
Recombinant anti-tumor and anti-virus protein for injection, Brand name: Novaferon, Saline Injection
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences, Beijing Genova Biotech Company, Ltd.
Metastatic Colorectal Cancer
05/13
05/14
NCT02455596: Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors

Unknown status
2
20
RoW
Recombinant anti-tumor and anti-virus protein for injection (Novaferon), Novaferon
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Neuroendocrine Tumors
10/16
12/16
NCT02068131: Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer

Unknown status
2
30
RoW
Novaferon, Capecitabine, Brand name:Xeloda
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Metastatic Colorectal Cancer
11/16
12/16
ChiCTR-TRC-10000984: Randomized double-blinding controlled multicenter trial of Novaferon for Chronic hepatitis B

Completed
1/2
360
 
Novaferon, intramuscular injection ;interferon alpha 2b, intramuscular injection
The XiangYa Hospital, ZhongNan University; Genova Biotech Company, Ltd, National Novel Drug Development plan
Chronic hepatitis B
 
 
NCT04380545: Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

Suspended
1/2
15
US
Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-Fu, 5FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Nivolumab, BMS-936558, MDX-1106, NIVO, ONO-4538, Opdivo, Recombinant Interferon Alpha 2b-like Protein, Novaferon, Recombinant IFN Alfa-2b-like Protein
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Fibrolamellar Carcinoma
07/25
07/25

Download Options